Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) Return on Capital Employed (2021 - 2026)

Envoy Medical's Return on Capital Employed history spans 5 years, with the latest figure at 331.31% for Q1 2026.

  • On a quarterly basis, Return on Capital Employed rose 24733.0% to 331.31% in Q1 2026 year-over-year; TTM through Mar 2026 was 331.31%, a 24733.0% increase, with the full-year FY2025 number at 1470.94%, up 228463.0% from a year prior.
  • Return on Capital Employed hit 331.31% in Q1 2026 for Envoy Medical, down from 697.57% in the prior quarter.
  • Over the last five years, Return on Capital Employed for COCH hit a ceiling of 4414.68% in Q2 2024 and a floor of 38921.9% in Q3 2025.
  • Historically, Return on Capital Employed has averaged 2571.41% across 5 years, with a median of 158.66% in 2023.
  • Biggest five-year swings in Return on Capital Employed: soared 445053bps in 2024 and later tumbled -4105011bps in 2025.
  • Tracing COCH's Return on Capital Employed over 5 years: stood at 3.34% in 2022, then plummeted by -7281bps to 246.17% in 2023, then crashed by -167bps to 657.35% in 2024, then skyrocketed by 206bps to 697.57% in 2025, then tumbled by -147bps to 331.31% in 2026.
  • Business Quant data shows Return on Capital Employed for COCH at 331.31% in Q1 2026, 697.57% in Q4 2025, and 38921.9% in Q3 2025.